关于公司
- 法定名称: HUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD.
- 注册国家: China
- 地址: Longping Wuli, Wuxue
- 员工人数: 250 - 499
描述:
Established in January 2008 with registered capital of 122 million yuan and listed on the NEEQ in April 2017, Hubei Longxiang Pharmaceutical Tech has more than 340 employees and total assets of 560 million yuan. A high-tech private enterprise integrating research, production and marketing, the company ranks among China's top ten veterinary API manufacturers and is recognized as a National High-Tech Enterprise, with main products including toltrazuril, ponazuril, florfenicol, tilmicosin, valnemulin hydrochloride, oxolinic acid, fluralaner and permethrin.
业务活动
原料药 (API)
制造商合同制造商(CMO)原料药生产商
医药化学品
制造商合同制造商(CMO)原料药生产商
ATC(解剖学-治疗学-化学)分类系统
制造商合同制造商(CMO)原料药生产商
原研原料药
制造商合同制造商(CMO)原料药生产商
销售市场
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany, Luxembourg, Netherlands
我们的产品与服务
Sell · Active Pharmaceutical Ingredients (APIs)
HUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD.
ChinaHUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD. sell "Toltrazuril,Ponazuril, Florfenicol, Tilmicosin, Valnemulin Hydrochloride, Oxolinic Acid, Menbutone, Fluralaner, Amprolium HCL,Pyriproxyfen and Permethrin"
Manufacturer: HUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD., China
Certifications
ISO
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论